Biopharmaceutical Production
Services include leading-edge development of monoclonal antibodies, recombinant proteins, peptide and DNA vaccines, virus vaccines and oncolytic virus, gene therapy products, and other biological agents.
Biopharmaceutical Production
Services include leading-edge development of monoclonal antibodies, recombinant proteins, peptide and DNA vaccines, virus vaccines and oncolytic virus, gene therapy products, and other biological agents.
SAIC-Frederick operates a current Good Manufacturing Practices-compliant facility that provides complete support from feasibility through development and manufacturing to filing of the regulatory documentation.
Contact Us
For access to these and other technologies, please see the Biopharmaceutical Development Program section on the NCI−Frederick web site or contact:
George Mitra, Ph.D.
Program and Technical Director
(301) 846-5999
(301) 846-6203 Fax
mitrag@mail.nih.gov
John A. Gilly, Ph.D.
Deputy Director
(301) 846-5808
(301) 846-6886 Fax
gillyj@mail.nih.gov